Table 1. Age distribution according to HPV genotyping results*.
| Age group (yr) | Total | HR-HPV (+) | HPV-16/18 (+) | Non-16/18 HR-HPV (+) |
|---|---|---|---|---|
| ≤29 | 195 | 123 (63.1) | 46 (23.6) | 77 (39.5) |
| 30–39 | 327 | 190 (58.1) | 89 (27.2) | 101 (30.9) |
| 40–49 | 340 | 153 (45.0) | 53 (15.6) | 100 (29.4) |
| 50–59 | 169 | 68 (40.2) | 25 (14.8) | 43 (25.4) |
| ≥60 | 71 | 43 (60.6) | 18 (25.3) | 25 (35.2) |
| Overall | 1,102† | 577 (52.4) | 231 (21.0) | 346 (31.4) |
Values are presented as number (%).
HPV, human papillomavirus; HR, high-risk.
*HR-HPV (+) includes HPV-16 (+) and/or HPV-18 (+) and/or 12 other non-16/18 HR-HPV (+); HPV-16/18 (+) includes HPV-16 (+) and/or HPV-18 (+), with or without any other HPV genotypes (+); non-16/18 HR-HPV (+) includes HPV-16 (–) and HPV-18 (–), 12 other HR-HPV (+) with or without low-risk HPV (+) or 'HPV-other types' (+); among all 1,102 cases, 113 cases were infected with multiple HPV genotypes, and they were classified as the group with the higher risk for its constituents. †Evaluable subjects with valid HPV results and valid biopsy results.